We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Qualified Antibodies for Autophagy Research

Want a FREE PDF version of this product news?

Complete the form below and we will email you a PDF version of "Qualified Antibodies for Autophagy Research"

Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time:

AMSBIO has assembled an extensive collection of autophagy antibodies. From the industry standard autophagy antibody APG8 (MAPLC3) to the newest autophagy antibodies such as LAMP and APG1, AMSBIO is able to provide the most relevant, qualified antibodies for autophagy research.

Autophagy is a cellular process not only implicated in the death of a cell, but more widely implicated in the survival of a cell.

Autophagy functions as a housekeeping mechanism through disposal of aging and/or dysfunctional proteins and organelles by isolating and preparing these proteins for lysosomal degradation.

Targeting autophagy as a therapeutic method is of growing interest to many researchers specializing in a diverse range of diseases from bacterial and viral infections to cancer and more recently in neurodegeneration and other ageing-related diseases.

Mitochondrial dysfunction has also become increasingly linked to various diseases, with mitophagy playing an important role in mitochondrial dynamics. AMSBIO provide a MitoXpress® Xtra Oxygen Consumption Assay for analysis in real-time of mitochondrial function using fluorescence plate readers.

AMSBIO offers a comprehensive range of products related to autophagy for almost every gene and target of interest.